Diabetes, Autoimmune
13
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
7.7%
1 terminated out of 13 trials
85.7%
-0.8% vs benchmark
8%
1 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
Type 1 Diabetes Autonomic and Vascular Function
Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA
Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
Low-dose IL-2 in Established T1D - The "PROREG" Study
Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
Characteristics of Young-onset Diabetes in Sub-Saharan Africa (YODA) Study
Early Insulin Treatment in Patients With Latent Autoimmune Diabetes
Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)